NYSE American - Delayed Quote • USD
Matinas BioPharma Holdings, Inc. (MTNB)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:26 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.03 | -0.03 | -0.12 | -0.1 |
| Low Estimate | -0.03 | -0.03 | -0.12 | -0.1 |
| High Estimate | -0.03 | -0.03 | -0.12 | -0.1 |
| Year Ago EPS | -0.03 | -0.03 | -0.11 | -0.12 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 1.1M | -- | 1.1M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Actual | -0.03 | -0.03 | -0.03 | -0.02 |
| Difference | 0 | 0 | 0 | 0.01 |
| Surprise % | 0.00% | 0.00% | 0.00% | 33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.03 | -0.12 | -0.1 |
| 7 Days Ago | -0.03 | -0.03 | -0.12 | -0.1 |
| 30 Days Ago | -0.03 | -0.03 | -0.11 | -0.1 |
| 60 Days Ago | 0 | 0 | -0.12 | -0.1 |
| 90 Days Ago | 0 | 0 | -0.12 | -0.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MTNB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 0.00% | -- | -- | 5.40% |
| Next Qtr. | 0.00% | -- | -- | 10.90% |
| Current Year | -9.10% | -- | -- | 4.50% |
| Next Year | 16.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy | 1/31/2023 |
| Maintains | Aegis Capital: Buy | 8/13/2020 |
| Initiated | Piper Sandler: Overweight | 1/27/2020 |
| Initiated | SunTrust Robinson Humphrey: Buy | 1/24/2020 |
| Initiated | HC Wainwright & Co.: Buy | 6/26/2019 |
| Initiated | BTIG: Buy | 5/17/2019 |
Related Tickers
ACST Acasti Pharma Inc.
2.9000
-2.03%
TOVX Theriva Biologics, Inc.
0.4195
+2.33%
DARE Daré Bioscience, Inc.
0.3059
+5.77%
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
TCON TRACON Pharmaceuticals, Inc.
1.8100
+1.12%
EQ Equillium, Inc.
1.7100
-5.52%
PXMD PaxMedica, Inc.
0.7398
+5.06%
RNAC Cartesian Therapeutics, Inc.
21.03
+0.62%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
KZR Kezar Life Sciences, Inc.
0.8049
+1.89%